Common Errors in IND-enabling Toxicology Programs

In this podcast, we discuss 5 common errors in designing and managing IND-enabling toxicology programs with a special guest: Glenn Washer, EVP of Global Safety and Toxicology at Frontage Laboratories, Inc.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Phone

This field is for validation purposes and should be left unchanged.

Common Errors in IND-enabling Toxicology Programs

Resources to Consider

Safety and Toxicology Services Brochure

6 Reasons To Do Exploratory Toxicology for Successful GLP Studies

The role of genetic toxicology in drug development

Toxicology Services

Genetic Toxicology

Safety and Toxicology Virtual Tour

Human Gut Microbiome-Based Contract Research Applications in...

Before GLP: The Value of Robust Exploratory Toxicology

The Value Of Robust Exploratory Toxicology Testing Prior To Pivotal...

Best Practices in Managing IND Programs with CROs

No-observed-adverse-effect level (NOAEL) in IND Programs